JOHN MARAGANORE Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN MARAGANORE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN MARAGANORE. JOHN MARAGANORE is CEO in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and Chief Executive Officer in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and President & CEO in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and President and CEO in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and Director in bluebird bio, Inc. ($BLUE) and Director in AGIOS PHARMACEUTICALS INC ($AGIO).
Latest Insider Trading Transactions of JOHN MARAGANORE
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGIO, ALNY, BLUE
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 02 2021 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Option Exercise | M | 0.00 | 1,686 | 0 | 0 | |
| Jun 02 2021 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Buy | M | 0.00 | 1,686 | 0 | 28,443 | 26.8 K to 28.4 K (+6.30 %) |
| Jun 02 2021 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Gift | G | 0.00 | 3,415 | 0 | 26,757 | 30.2 K to 26.8 K (-11.32 %) |
| May 17 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 7.10 | 33,979 | 241,251 | 67,957 | |
| May 17 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 134.37 | 1,023 | 137,461 | 214,765 | 215.8 K to 214.8 K (-0.47 %) |
| May 17 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 133.56 | 1,624 | 216,901 | 215,788 | 217.4 K to 215.8 K (-0.75 %) |
| May 17 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 132.32 | 3,481 | 460,606 | 217,412 | 220.9 K to 217.4 K (-1.58 %) |
| May 17 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 131.18 | 11,203 | 1,469,610 | 220,893 | 232.1 K to 220.9 K (-4.83 %) |
| May 17 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 130.34 | 9,121 | 1,188,831 | 232,096 | 241.2 K to 232.1 K (-3.78 %) |
| May 17 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 129.32 | 4,512 | 583,492 | 241,217 | 245.7 K to 241.2 K (-1.84 %) |
| May 17 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 128.30 | 3,015 | 386,825 | 245,729 | 248.7 K to 245.7 K (-1.21 %) |
| May 17 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 7.10 | 33,979 | 241,251 | 248,744 | 214.8 K to 248.7 K (+15.82 %) |
| Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Payment of Exercise | F | 134.62 | 270 | 36,347 | 214,765 | 215 K to 214.8 K (-0.13 %) |
| Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Payment of Exercise | F | 131.75 | 7,237 | 953,475 | 215,035 | 222.3 K to 215 K (-3.26 %) |
| Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Grant | A | 0.00 | 16,236 | 0 | 222,272 | 206 K to 222.3 K (+7.88 %) |
| Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 7.10 | 33,979 | 241,251 | 101,936 | |
| Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 151.59 | 79,998 | 12,126,897 | 79,998 | |
| Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 154.59 | 599 | 92,599 | 206,036 | 206.6 K to 206 K (-0.29 %) |
| Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 153.33 | 431 | 66,085 | 206,635 | 207.1 K to 206.6 K (-0.21 %) |
| Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 152.46 | 1,138 | 173,499 | 207,066 | 208.2 K to 207.1 K (-0.55 %) |
| Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 151.31 | 1,415 | 214,104 | 208,204 | 209.6 K to 208.2 K (-0.68 %) |
| Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 150.22 | 2,054 | 308,552 | 209,619 | 211.7 K to 209.6 K (-0.97 %) |
| Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 148.96 | 1,364 | 203,181 | 211,673 | 213 K to 211.7 K (-0.64 %) |
| Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 148.00 | 4,375 | 647,500 | 213,037 | 217.4 K to 213 K (-2.01 %) |
| Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 146.98 | 6,097 | 896,137 | 217,412 | 223.5 K to 217.4 K (-2.73 %) |
| Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 146.13 | 9,376 | 1,370,115 | 223,509 | 232.9 K to 223.5 K (-4.03 %) |
| Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 145.15 | 6,129 | 889,624 | 232,885 | 239 K to 232.9 K (-2.56 %) |
| Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 143.88 | 1,001 | 144,024 | 239,014 | 240 K to 239 K (-0.42 %) |
| Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 7.10 | 33,979 | 241,251 | 240,015 | 206 K to 240 K (+16.49 %) |
| Nov 20 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 9.14 | 34,765 | 317,752 | 0 | |
| Nov 20 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 126.62 | 102 | 12,915 | 197,589 | 197.7 K to 197.6 K (-0.05 %) |
| Nov 20 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 125.35 | 10,187 | 1,276,940 | 197,691 | 207.9 K to 197.7 K (-4.90 %) |
| Nov 20 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 124.49 | 5,489 | 683,326 | 207,878 | 213.4 K to 207.9 K (-2.57 %) |
| Nov 20 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 123.55 | 18,987 | 2,345,844 | 213,367 | 232.4 K to 213.4 K (-8.17 %) |
| Nov 20 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 9.14 | 34,765 | 317,752 | 232,354 | 197.6 K to 232.4 K (+17.59 %) |
| Aug 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 9.14 | 34,765 | 317,752 | 34,765 | |
| Aug 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 136.86 | 8,542 | 1,169,058 | 197,589 | 206.1 K to 197.6 K (-4.14 %) |
| Aug 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 136.07 | 21,448 | 2,918,429 | 206,131 | 227.6 K to 206.1 K (-9.42 %) |
| Aug 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 135.09 | 4,775 | 645,055 | 227,579 | 232.4 K to 227.6 K (-2.06 %) |
| Aug 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 9.14 | 34,765 | 317,752 | 232,354 | 197.6 K to 232.4 K (+17.59 %) |
| Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Option Exercise | M | 0.00 | 1,878 | 0 | 0 | |
| Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Option Exercise | A | 0.00 | 1,686 | 0 | 1,686 | |
| Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Option Exercise | A | 53.35 | 8,096 | 431,922 | 8,096 | |
| Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Buy | M | 0.00 | 1,878 | 0 | 30,172 | 28.3 K to 30.2 K (+6.64 %) |
| May 22 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 9.14 | 34,765 | 317,752 | 69,530 | |
| May 22 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 144.33 | 5,013 | 723,526 | 197,589 | 202.6 K to 197.6 K (-2.47 %) |
| May 22 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 143.46 | 16,315 | 2,340,550 | 202,602 | 218.9 K to 202.6 K (-7.45 %) |
| May 22 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 142.51 | 13,437 | 1,914,907 | 218,917 | 232.4 K to 218.9 K (-5.78 %) |
| May 22 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 9.14 | 34,765 | 317,752 | 232,354 | 197.6 K to 232.4 K (+17.59 %) |
| Apr 09 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Payment of Exercise | F | 106.27 | 256 | 27,205 | 197,589 | 197.8 K to 197.6 K (-0.13 %) |
| Apr 09 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Payment of Exercise | F | 104.75 | 6,315 | 661,496 | 197,845 | 204.2 K to 197.8 K (-3.09 %) |
| Apr 09 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Grant | A | 0.00 | 14,167 | 0 | 204,160 | 190 K to 204.2 K (+7.46 %) |
| Feb 28 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 118.05 | 88,240 | 10,416,732 | 88,240 | |
| Feb 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 9.14 | 34,765 | 317,752 | 104,295 | |
| Feb 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 133.42 | 502 | 66,977 | 189,993 | 190.5 K to 190 K (-0.26 %) |
| Feb 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 132.81 | 18,065 | 2,399,213 | 190,495 | 208.6 K to 190.5 K (-8.66 %) |
| Feb 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 131.61 | 6,887 | 906,398 | 208,560 | 215.4 K to 208.6 K (-3.20 %) |
| Feb 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 131.07 | 5,053 | 662,297 | 215,447 | 220.5 K to 215.4 K (-2.29 %) |
| Feb 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 129.33 | 1,586 | 205,117 | 220,500 | 222.1 K to 220.5 K (-0.71 %) |
| Feb 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 128.62 | 2,672 | 343,673 | 222,086 | 224.8 K to 222.1 K (-1.19 %) |
| Feb 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 9.14 | 34,765 | 317,752 | 224,758 | 190 K to 224.8 K (+18.30 %) |
| Dec 26 2019 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 119.13 | 17,498 | 2,084,537 | 34,996 | |
| Nov 26 2019 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 119.13 | 17,498 | 2,084,537 | 17,498 | |
| Oct 16 2019 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 16.43 | 49,456 | 812,562 | 0 | |
| Oct 16 2019 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 80.31 | 1,870 | 150,180 | 189,993 | 191.9 K to 190 K (-0.97 %) |
| Oct 16 2019 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 79.80 | 26,754 | 2,134,969 | 191,863 | 218.6 K to 191.9 K (-12.24 %) |
| Oct 16 2019 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 78.92 | 20,832 | 1,644,061 | 218,617 | 239.4 K to 218.6 K (-8.70 %) |
| Oct 16 2019 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 16.43 | 49,456 | 812,562 | 239,449 | 190 K to 239.4 K (+26.03 %) |
| Aug 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 42.22 | 6,250 | 263,875 | 25,000 | |
| Aug 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 88.95 | 16,250 | 1,445,438 | 65,000 | |
| Aug 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | J | 0.00 | 34 | 0 | 3,133 | 3.1 K to 3.1 K (+1.10 %) |
| Jun 14 2019 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Gift | G | 0.00 | 5,000 | 0 | 32,609 | 37.6 K to 32.6 K (-13.29 %) |
| Jun 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 42.22 | 6,250 | 263,875 | 18,750 | |
| May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Option Exercise | M | 0.00 | 1,400 | 0 | 0 | |
| May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Option Exercise | A | 0.00 | 1,878 | 0 | 1,878 | |
| May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Option Exercise | A | 47.91 | 8,919 | 427,309 | 8,919 | |
| May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Buy | M | 0.00 | 1,400 | 0 | 37,609 | 36.2 K to 37.6 K (+3.87 %) |
| May 17 2019 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 16.43 | 49,457 | 812,579 | 49,456 | |
| May 17 2019 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | J | 0.00 | 61 | 0 | 3,099 | 3 K to 3.1 K (+2.01 %) |
| May 17 2019 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 70.00 | 49,457 | 3,461,990 | 189,993 | 239.5 K to 190 K (-20.65 %) |
| May 17 2019 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 16.43 | 49,457 | 812,579 | 239,450 | 190 K to 239.5 K (+26.03 %) |
| Mar 01 2019 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 85.00 | 85,000 | 7,225,000 | 85,000 | |
| Nov 26 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 21.35 | 98,636 | 2,105,879 | 0 | |
| Nov 26 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | J | 0.00 | 17 | 0 | 3,038 | 3 K to 3 K (+0.56 %) |
| Nov 26 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Payment of Exercise | F | 72.68 | 59,940 | 4,356,439 | 189,993 | 249.9 K to 190 K (-23.98 %) |
| Nov 26 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 21.35 | 98,636 | 2,105,879 | 249,933 | 151.3 K to 249.9 K (+65.19 %) |
| Sep 28 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 42.22 | 6,250 | 263,875 | 12,500 | |
| Sep 28 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 88.95 | 16,250 | 1,445,438 | 48,750 | |
| Sep 13 2018 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Sell | S | 71.74 | 14,162 | 1,015,982 | 22,047 | 36.2 K to 22 K (-39.11 %) |
| Sep 13 2018 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Sell | S | 73.82 | 2,400 | 177,168 | 36,209 | 38.6 K to 36.2 K (-6.22 %) |
| Sep 13 2018 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Sell | S | 72.52 | 11,155 | 808,961 | 38,609 | 49.8 K to 38.6 K (-22.42 %) |
| Aug 23 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 88.95 | 16,250 | 1,445,438 | 32,500 | |
| Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 96.45 | 25,000 | 2,411,250 | 75,000 | |
| Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 63.00 | 25,000 | 1,575,000 | 75,000 | |
| Jul 27 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 21.35 | 50,000 | 1,067,500 | 98,636 | |
| Jul 27 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | J | 0.00 | 31 | 0 | 3,021 | 3 K to 3 K (+1.04 %) |
| Jul 27 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | J | 0.00 | 30 | 0 | 2,990 | 3 K to 3 K (+1.01 %) |
| Jul 27 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 106.25 | 1,400 | 148,750 | 151,297 | 152.7 K to 151.3 K (-0.92 %) |
| Jul 27 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 105.83 | 34,995 | 3,703,521 | 152,697 | 187.7 K to 152.7 K (-18.64 %) |
| Jul 27 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 104.83 | 7,758 | 813,271 | 187,692 | 195.5 K to 187.7 K (-3.97 %) |
| Jul 27 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 103.69 | 3,847 | 398,895 | 195,450 | 199.3 K to 195.5 K (-1.93 %) |
| Jul 27 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 102.51 | 2,000 | 205,020 | 199,297 | 201.3 K to 199.3 K (-0.99 %) |
| Jul 27 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 21.35 | 50,000 | 1,067,500 | 201,297 | 151.3 K to 201.3 K (+33.05 %) |
| Jun 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Option Exercise | A | 0.00 | 1,400 | 0 | 1,400 | |
| Jun 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Option Exercise | A | 93.50 | 5,700 | 532,950 | 5,700 | |
| Mar 05 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 119.13 | 52,500 | 6,254,325 | 52,500 | |
| Dec 21 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 63.00 | 1,587 | 99,981 | 148,413 | |
| Dec 21 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 42.22 | 6,250 | 263,875 | 6,250 | |
| Dec 21 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 63.00 | 1,587 | 99,981 | 151,297 | 149.7 K to 151.3 K (+1.06 %) |
| Nov 24 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 31.39 | 73,415 | 2,304,497 | 0 | |
| Nov 24 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 132.73 | 2,683 | 356,115 | 149,710 | 152.4 K to 149.7 K (-1.76 %) |
| Nov 24 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 131.82 | 20,433 | 2,693,478 | 152,393 | 172.8 K to 152.4 K (-11.82 %) |
| Nov 24 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 130.88 | 25,036 | 3,276,712 | 172,826 | 197.9 K to 172.8 K (-12.65 %) |
| Nov 24 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 129.97 | 25,263 | 3,283,432 | 197,862 | 223.1 K to 197.9 K (-11.32 %) |
| Nov 24 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 31.39 | 73,415 | 2,304,497 | 223,125 | 149.7 K to 223.1 K (+49.04 %) |
| Nov 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 31.39 | 74,000 | 2,322,860 | 73,415 | |
| Nov 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 130.22 | 600 | 78,131 | 149,710 | 150.3 K to 149.7 K (-0.40 %) |
| Nov 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 129.57 | 4,850 | 628,415 | 150,310 | 155.2 K to 150.3 K (-3.13 %) |
| Nov 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 128.48 | 10,571 | 1,358,204 | 155,160 | 165.7 K to 155.2 K (-6.38 %) |
| Nov 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 127.54 | 7,120 | 908,085 | 165,731 | 172.9 K to 165.7 K (-4.12 %) |
| Nov 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 126.60 | 28,399 | 3,595,399 | 172,851 | 201.3 K to 172.9 K (-14.11 %) |
| Nov 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 125.54 | 22,460 | 2,819,718 | 201,250 | 223.7 K to 201.3 K (-10.04 %) |
| Nov 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 31.39 | 74,000 | 2,322,860 | 223,710 | 149.7 K to 223.7 K (+49.43 %) |
| Nov 08 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 88.95 | 16,250 | 1,445,438 | 16,250 | |
| Sep 22 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 63.00 | 25,000 | 1,575,000 | 25,000 | |
| Sep 18 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Option Exercise | M | 2.09 | 18,868 | 39,434 | 0 | |
| Sep 18 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Sell | S | 131.82 | 600 | 79,090 | 5,843 | 6.4 K to 5.8 K (-9.31 %) |
| Sep 18 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Sell | S | 131.19 | 18,268 | 2,396,643 | 6,443 | 24.7 K to 6.4 K (-73.93 %) |
| Sep 18 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Buy | M | 2.09 | 18,868 | 39,434 | 24,711 | 5.8 K to 24.7 K (+322.92 %) |
| Aug 28 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Option Exercise | M | 2.09 | 13,839 | 28,924 | 18,868 | |
| Aug 28 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Sell | S | 96.74 | 2,754 | 266,425 | 5,843 | 8.6 K to 5.8 K (-32.03 %) |
| Aug 28 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Sell | S | 96.32 | 6,385 | 615,019 | 8,597 | 15 K to 8.6 K (-42.62 %) |
| Aug 28 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Sell | S | 95.13 | 4,700 | 447,089 | 14,982 | 19.7 K to 15 K (-23.88 %) |
| Aug 28 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Buy | M | 2.09 | 13,839 | 28,924 | 19,682 | 5.8 K to 19.7 K (+236.85 %) |
| Jul 11 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 96.45 | 25,000 | 2,411,250 | 50,000 | |
| Jun 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Option Exercise | A | 50.73 | 8,000 | 405,840 | 8,000 | |
| Jun 12 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Option Exercise | A | 111.00 | 4,000 | 444,000 | 4,000 | |
| Jun 12 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Grant | A | 0.00 | 1,000 | 0 | 5,843 | 4.8 K to 5.8 K (+20.65 %) |
| Mar 06 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Option Exercise | M | 5.50 | 12,917 | 71,049 | 0 | |
| Mar 06 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Option Exercise | M | 0.95 | 922 | 874 | 0 | |
| Mar 06 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Sell | S | 85.02 | 13,839 | 1,176,646 | 4,843 | 18.7 K to 4.8 K (-74.08 %) |
| Mar 06 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Buy | M | 5.50 | 12,917 | 71,049 | 18,682 | 5.8 K to 18.7 K (+224.06 %) |
| Mar 06 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Buy | M | 0.95 | 922 | 874 | 5,765 | 4.8 K to 5.8 K (+19.04 %) |
| Jan 23 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Gift | G | 0.00 | 1,450 | 0 | 4,843 | 6.3 K to 4.8 K (-23.04 %) |
| Jan 06 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 18.66 | 1,340 | 25,004 | 144,641 | |
| Jan 06 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 18.66 | 1,340 | 25,004 | 149,710 | 148.4 K to 149.7 K (+0.90 %) |
| Dec 22 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 42.22 | 25,000 | 1,055,500 | 25,000 | |
| Dec 14 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 22.75 | 30,151 | 685,935 | 0 | |
| Dec 14 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Payment of Exercise | F | 42.61 | 22,710 | 967,673 | 148,370 | 171.1 K to 148.4 K (-13.27 %) |
| Dec 14 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 22.75 | 30,151 | 685,935 | 171,080 | 140.9 K to 171.1 K (+21.39 %) |